Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer
- PMID: 7500985
- DOI: 10.1016/0027-5107(95)00161-8
Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer
Abstract
A clonal assay to determine the mutant frequency (MF) at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus in human lymphocytes has been used by a number of investigators to study exposure to mutagens and carcinogens in a variety of populations. We have studied hprt MF in 106 subjects (40 controls and 66 cases) enrolled in a case-control investigation of lung cancer. Epidemiological data collected included smoking history, intake of dietary micronutrients, and occupational and environmental exposures as well as medical history, all obtained from an interviewer-administered questionnaire. All subjects were also genotyped for the known polymorphism in glutathione S-transferase class mu (GST-mu). In analysis of cases and controls, hprt MF was not associated with age, smoking, the polymorphism in GST mu, dietary intake, occupational exposures, family history of cancer or usage of medications. Since MF and cloning efficiency (CE) are not independent when CE is low, further analysis in cases and controls with a CE greater than or equal to 30% (27 cases and 22 controls) was also conducted. In analysis of controls, hprt MF increased with age and was inversely associated with intake of folate and vitamins A and C. The presence of lung cancer was not associated with hprt MF. Thus, our study supports the previous observation that dietary components may affect the MF at the hprt locus.
Similar articles
-
Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals.Environ Mol Mutagen. 1995;25(2):97-105. doi: 10.1002/em.2850250203. Environ Mol Mutagen. 1995. PMID: 7698112
-
Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.Mutat Res. 2000 Jun 22;468(1):45-61. doi: 10.1016/s1383-5718(00)00039-5. Mutat Res. 2000. PMID: 10863157
-
Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls.Carcinogenesis. 1999 Mar;20(3):437-44. doi: 10.1093/carcin/20.3.437. Carcinogenesis. 1999. PMID: 10190559
-
Cancer chemotherapy and somatic cell mutation.Mutat Res. 2000 Oct 31;470(2):93-102. doi: 10.1016/s1383-5742(00)00043-0. Mutat Res. 2000. PMID: 11027962 Review.
-
Factors contributing to discrepancies in population monitoring studies.Mutat Res. 1998 May 25;400(1-2):467-78. doi: 10.1016/s0027-5107(98)00058-x. Mutat Res. 1998. PMID: 9685705 Review.
Cited by
-
A review of HPRT and its emerging role in cancer.Med Oncol. 2018 May 5;35(6):89. doi: 10.1007/s12032-018-1144-1. Med Oncol. 2018. PMID: 29730818 Review.
-
Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects.Environ Health Perspect. 1998 Feb;106 Suppl 1(Suppl 1):231-9. doi: 10.1289/ehp.106-1533289. Environ Health Perspect. 1998. PMID: 9539016 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous